Risk factors for multiple myeloma

A risk factor is something that increases the risk of developing cancer. It could be a behaviour, substance or condition. Most cancers are the result of many risk factors. But sometimes multiple myeloma develops in people who don’t have any of the risk factors described below.

More men than women are diagnosed with multiple myeloma. The risk for multiple myeloma increases with age. People of African ancestry have a higher risk of developing multiple myeloma. The reasons for this increased risk are not known.

Risk factors are generally listed in order from most to least important. But in most cases, it is impossible to rank them with absolute certainty.

Risk factors

History of monoclonal gammopathy of undetermined significance (MGUS)

Family history of multiple myeloma

Obesity and overweight

Farming

Weakened immune system

There is convincing evidence that the following factors increase your risk for multiple myeloma.

History of monoclonal gammopathy of undetermined significance (MGUS)

MGUS is a plasma cell disorder that has the potential to develop into multiple myeloma. A plasma cell is a type of white blood cell that makes antibodies to help the body fight infection. Many of the known and possible risk factors for MGUS are the same as for multiple myeloma.

It is difficult to diagnose multiple myeloma early. Often it causes no symptoms until it is more advanced. People with MGUS may have regular blood work to monitor for multiple myeloma.

Family history of multiple myeloma

Multiple myeloma is more common in some families. The risk of developing multiple myeloma is nearly 4 times greater for a person who has a parent or sibling with multiple myeloma. Some studies show that there is a stronger risk in families of African ancestry. But most people with multiple myeloma have no family history of the disease.

Obesity and overweight

Multiple myeloma occurs more often in people with a high body mass index (BMI) than in those who have a healthy weight.

Farming

Many studies show that people who work on a farm have a higher risk of developing multiple myeloma. We need more research to understand what it is about farming that causes the increase in risk. Some studies suggest that being exposed to certain pesticides used in farming explains the increased risk. Pesticides include a large number of different chemicals, but only some pesticides are linked to multiple myeloma risk. Research also shows that working with farm animals, especially sheep, may increase your risk. It may be that it is the combination of being exposed to pesticides, animals or other factors that increases a person’s chance of developing multiple myeloma.

Weakened immune system

People with a weakened immune system (immunosuppression) have a higher risk of developing multiple myeloma. This includes people with HIV or AIDS and people who have had an organ transplant and must take medicines to suppress their immune system.

Possible risk factors

The following factors have been linked with multiple myeloma, but there is not enough evidence to show for sure that they are risk factors. More research is needed to clarify the role of these factors for multiple myeloma:

  • autoimmune conditions
  • viral infections such as hepatitis B and C
  • working in occupations such as petroleum production, machinery production or carpentry, which expose you to chemicals such as benzene, coal or wood dust

Questions to ask your healthcare team

To make the decisions that are right for you, ask your healthcare team questions about risks.

Expert review and references

  • Badras A. Epidemiology and risk factors of multiple myeloma: Insights into incidence and etiology. Sekeres, M. A., Kalaycio, M. E., & Bolwell, B. J. Clinical Malignant Hematology. New York: McGraw Hill Medical; 2007: IV(80): pp. 833-845.
  • Becker N, Byl A, Friedrich S, Jauch A, Schnitzler P, Egerer G, et al. Hepatitis B virus infection is associated with deletion of chromosome 8p in multiple myeloma. European Journal of Haematology. 2013:
  • Becker N1, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadie M, et al. Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. Journal of Cancer Research and Clinical Oncology. 2012:
  • Bethwaite PB, Pearce N, Fraser J. Cancer risks in painters: study based on the New Zealand Cancer Registry. British Journal of Industrial Medicine. 1990:
  • Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiation Research. 2013:
  • Rajkumar SV, Kyle RA, Lust JA. Monoclonal gammopathies of undetermined significance and smouldering multiple myeloma. Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, Rodgers GM, Foerster J, (eds.). Wintrobe's Clinical Hematology. 13th ed. Lippincott Williams & Wilkins; 2014: 97: 2029-2045.
  • International Agency for Research on Cancer (IARC). Volume 53: Occupational Exposures in Insecticide Application, and Some Pesticides. 1991:
  • International Agency for Research on Cancer (IARC). Volume 71: Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide. 1999:
  • International Agency for Research on Cancer (IARC). Volume 77: Some Industrial Chemicals. 2000:
  • International Agency for Research on Cancer (IARC). Volume 99: Some Aromatic Amines, Organic Dyes, and Related Exposures. 2010:
  • Ruder AM, Waters MA, Carreon T, et al. The Upper Midwest Health Study: industry and occupation of glioma cases and controls. American Journal of Industrial Medicine. Wiley; 2012:
  • Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014:
  • Myeloma Canada. What Causes Myeloma. Kirkland, QC: 2015: https://www.myelomacanada.ca/.
  • National Cancer Institute. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment PDQ®: Health Professional Version. National Cancer Institute; 2014: http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/healthprofessional.
  • Perrotta C1, Staines A, Codd M, Kleefeld S, Crowley D, T' Mannetje A, et al. Multiple Myeloma and lifetime occupation: results from the EPILYMPH study. Journal of Occupational Medicine and Toxicology. Biomed Central; 2012:
  • Johnson KJ, Cullen J, Barnholtz-Sloan JS, et al. Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review. Cancer Epidemiology, Biomarkers & Prevention. American Association for Cancer Research; 2014:

Reducing your risk for multiple myeloma

Ways to reduce your risk of multiple myeloma include maintaining a healthy body weight and eating well. Learn more about how to lower your risk of multiple myeloma.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society